Mild hyperbaric oxygen: mechanisms and effects

Mild hyperbaric oxygen: mechanisms and effects

Akihiko Ishihara - The Journal of Physiological Sciences Volume 69, Issue 4, July 2019, Pages 573-580
Oct 15, 2025
Mild hyperbaric oxygen: mechanisms and effects

The Journal of Physiological Sciences

Volume 69, Issue 4, July 2019, Pages 573-580

The Journal of Physiological Sciences

ReviewMild hyperbaric oxygen: mechanisms and effects

Author links open overlay panelAkihiko Ishihara 1

Show more

Add to Mendeley

Share

Cite

https://doi.org/10.1007/s12576-019-00678-5Get rights and content

Under a Creative Commons license

Open access

Abstract

Adequate oxygen supply by exposure to mild hyperbaric oxygen at appropriately high atmospheric pressure (1266–1317 hPa) and increased oxygen concentration (35–40% oxygen) has a possibility of improving the oxidative metabolism in cells and tissues without barotrauma and excessive production of reactive oxygen species. Therefore, metabolic syndrome and lifestyle-related diseases, including type 2 diabetes and hypertension, in rats were inhibited and/or improved by exposure to mild hyperbaric oxygen. It accelerated the growth-induced increase in oxidative capacity of the skeletal muscle in rats and inhibited the age-related decrease in oxidative capacity of the skeletal muscle in mice. A decrease in dopaminergic neurons in the substantia nigra of mice with Parkinson’s disease was inhibited by exposure to mild hyperbaric oxygen. This review describes the beneficial effects of exposure to mild hyperbaric oxygen on some metabolic diseases and their perspectives.

Keywords

Dissolved oxygen

Mild hyperbaric oxygen

Oxidative metabolism

Introduction

Oxygen is essential for energy production in most cells and is carried by red blood cells that flow in blood vessels. The oxygen bound to hemoglobin in red blood cells is referred to as the ‘oxygen bound to hemoglobin.’ The oxygen dissolved in blood plasma is referred to as the ‘dissolved oxygen.’ Although the quantity of dissolved oxygen is less than that of oxygen bound to hemoglobin, it can flow to peripheral cells, especially those in the brain, heart, and eyes, even if capillaries are very narrow, since it is dissolved directly in blood plasma (Fig. 1a).

Fig. 1
  1. Download: Download high-res image (210KB)

  2. Download: Download full-size image

Fig. 1. Schematic diagram depicting the distribution of oxygen bound to hemoglobin and dissolved oxygen in blood vessels under normobaric (a) and mild hyperbaric oxygen (b) conditions. Abundant hemoglobin is distributed in red blood cells, and up to four oxygen molecules can bind to one hemoglobin (oxygen bound to hemoglobin). The other kind of oxygen is dissolved in blood plasma (dissolved oxygen). The quantity of dissolved oxygen is less than that of oxygen bound to hemoglobin. Enhanced atmospheric pressure and/or oxygen concentration can increase oxygen in the body, especially dissolved oxygen in blood plasma. In addition, dissolved oxygen is able to flow to the peripheral cells, especially those in the brain, heart, and eyes, even if capillaries are very narrow, since it is dissolved directly in blood plasma

Enhanced atmospheric pressure and/or increased oxygen concentration can increase the oxygen content, especially the dissolved oxygen content in blood plasma [1, 2] (Fig. 1b). Exposure to mild hyperbaric oxygen at 1266–1317 hPa with 35–40% oxygen inhibited metabolic syndrome [3] and lifestyle-related diseases, including type 2 diabetes [4] and hypertension [5], in experimental animals since it improved oxidative metabolism, which was lower than that in controls [6].

However, side effects associated with enhanced atmospheric pressure and/or increased oxygen concentration, including barotrauma and excessive production of reactive oxygen species in tissues and organs, are thought to occur. Hyperbaric oxygen therapy at 2026–3039 hPa with 100% oxygen for medical treatment is associated with the risk of inducing myopia and cataracts [7., 8., 9.]. A previous study [7] reported that exposure to hyperbaric oxygen at 2534 hPa with 100% oxygen for 2–2.5 h, twice a week, up to 100 sessions, induces cataracts in guinea pigs. Similarly, myopia and cataracts developed in human lenses after exposure to prolonged hyperbaric conditions of 2026–2534 hPa with 100% oxygen for 90 min, once a day, from 150 to 850 sessions [8]; however, it was rarely seen to occur after only 48 sessions of hyperbaric oxygen conditions at 2534 hPa for 90 min [9]. Hyperbaric oxygen therapy increases the number of invasive inflammatory cells in mice [10] and causes excessive production of reactive oxygen species in rats [11, 12], rabbits [13], and humans [14]. Excessive production of reactive oxygen species plays a key role in the pathogenesis of many diseases and their complications; generation of free radicals and increased levels of oxidative stress are associated with atherosclerosis, cataracts, retinopathy, myocardial infarction, hypertension, diabetes, renal failure, and uremia [15., 16., 17.]. In addition, regardless of pressure, oxygen treatments involving > 40% oxygen have shown adverse effects, e.g., damage of erythrocytes due to reactive oxygen species and reduced quantity of oxygen bound to hemoglobin in rats [18].

Exposure to mild hyperbaric oxygen at a low oxygen concentration (35–40% oxygen) does not result in enhanced levels of oxidative stress in rats [5, 19] and humans [20]. Based on previous findings from experimental animal and human clinical studies, the effects of exposure to mild hyperbaric oxygen at 1266–1317 hPa with 35–40% oxygen are summarized in Table 1. It is noteworthy that these findings were obtained in the first step of exposure to mild hyperbaric oxygen. Therefore, it is expected to define a suitable recommendation regarding a generally applicable protocol for exposure to mild hyperbaric oxygen in the subsequent step. This review describes the beneficial effects of exposure to mild hyperbaric oxygen on some metabolic diseases and related perspectives.

Table 1. Effects of exposure to mild hyperbaric oxygen reported in previous studies

Empty CellSpeciesEffectsReferencesMetabolic syndromeSHR/NDmcr-cp ratInhibition of metabolic syndrome[3]Type 2 diabetesGK ratInhibition of type 2 diabetes[4, 36, 37]OLETF ratInhibition of type 2 diabetes[38]GK ratImprovement of type 2 diabetes[39]Diabetes-induced cataractsRepeated inbreeding of diabetic mouseInhibition of cataracts[46]HypertensionSHRInhibition of hypertension[5]ArthritisCollagen-induced DA ratInhibition of arthritis[19]Parkinson’s diseaseMTPT-injected C57BL/6JJmsSlc mouseInhibition of decrease in dopaminergic neuron[86]PigmentationMale subject irradiated with UVBMelanin pigmentation turns light[62]Female subjectSenile spot size becomes small[62]ProliferationAged hairless (Hos, HR-1) mouseImprovement of proliferative activity of epidermal basal cell[60]MetabolismHumanDecrease in SpO2, increase in resting HR and energy expenditure[20]Skeletal muscle fiberWistar ratIncrease in oxidative capacity[63, 64]Wistar ratInhibition of atrophy[83]Aged ICR mouseImprovement of oxidative capacity[69]Spinal motoneuronWistar ratIncrease in oxidative capacity[63, 64]GK ratImprovement of oxidative capacity[44]InfertilityWoman with intractable infertilityImprovement of the outcome of in vitro fertilization[96]

SHR spontaneously hypertensive rat, GK Goto-Kakizaki, OLETF Otsuka Long-Evans Tokushima Fatty, DA dark Agouti, UVB ultraviolet B, ICR Institute of Cancer Research, MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride, SpO2 peripheral oxygen saturation, HR heart rate

Metabolic syndrome

Metabolic syndrome, linked to chronic physical inactivity and consumption of a high-fat and high-calorie diet, is characterized by obesity, high blood pressure, and increased blood glucose, low density lipoprotein-cholesterol, and triglyceride levels [21, 22]. Experimental animals with metabolic syndrome have a nonsense mutation in the leptin receptor [23, 24]. Rats with metabolic syndrome have a low oxidative capacity in the skeletal muscle compared to normal rats [6, 25]. Reduced oxidative capacity in the skeletal muscle is suggested to impair glucose metabolism and increase the risk of development of metabolic syndrome [6, 21, 22, 25]. Rats with metabolic syndrome exposed to mild hyperbaric oxygen had lower blood pressure, blood glucose, total cholesterol, triglyceride, and insulin levels, but higher adiponectin levels than those not exposed to mild hyperbaric oxygen [3]. In addition, rats with metabolic syndrome exposed to mild hyperbaric oxygen had high oxidative capacity and increased levels of peroxisome proliferator-activated receptor γ coactivator-1α (Pgc-1α) mRNA, which plays an important role in oxidative metabolism by regulating mitochondrial biogenesis in the skeletal muscle [26, 27].

Exposure to mild hyperbaric oxygen is thus considered to inhibit the growth-related increase in blood glucose levels and decrease the muscle oxidative capacity of rats with metabolic syndrome owing to the improved oxidative metabolism [3].

Type 2 diabetes

In general, blood glucose, hemoglobin A1c (HbA1c), and triglyceride levels are higher in patients with diabetes than in healthy lean people. Hyperglycemia worsens vascular disorders including a stroke, myocardial infarction, retinopathy, nephropathy, and peripheral neuropathy. Patients with type 2 diabetes have decreased oxidative capacity in the skeletal muscle, similar to those with metabolic syndrome [28]. Decreased oxidative capacity in the skeletal muscle of patients with diabetes is suggested to be related to insulin resistance and impaired glucose metabolism. Both non-obese and obese rats with diabetes, which were developed as Goto-Kakizaki [29, 30] and Otsuka Long-Evans Tokushima Fatty [31] models, respectively, have lower oxidative capacity in the skeletal muscle than that of normal rats [32., 33., 34.]. Zucker diabetic fatty rats show similar muscle properties as obese rats with diabetes [35]. Blood glucose, HbA1c, and triglyceride levels were higher in non-obese and obese rats with diabetes than in normal rats [33, 34], and those levels improved by exposure to mild hyperbaric oxygen [4, 36]. In the skeletal muscle, Pgc-, myogenin, and myogenic factor 5 mRNA levels and oxidative capacity were higher in rats with diabetes exposed to mild hyperbaric oxygen than in those not exposed to mild hyperbaric oxygen [37, 38].

The growth-related increase in blood glucose levels in rats with type 2 diabetes was inhibited by exposure to mild hyperbaric oxygen [4, 36., 37., 38.]. The decreased blood glucose levels induced by exposure to mild hyperbaric oxygen in rats with type 2 diabetes were maintained even after these rats were subsequently returned to breeding under normobaric conditions [39]. The increased blood glucose levels of adult rats with type 2 diabetes not exposed to mild hyperbaric oxygen were lowered even if they were exposed to mild hyperbaric oxygen afterward [39]. These results indicate that low blood glucose levels in rats with type 2 diabetes can be maintained by exposure to mild hyperbaric oxygen compared to those not exposed to mild hyperbaric oxygen, both when blood glucose levels are increasing during growth [36., 37., 38.] and after blood glucose levels are high in adulthood [39].

Exposure to mild hyperbaric oxygen, therefore, seems to prevent the decrease in oxidative capacity of the skeletal muscle of rats with type 2 diabetes, irrespective of their age [36., 37., 38.]. In addition, exposure to mild hyperbaric oxygen is effective for the inhibition [4, 36., 37., 38.] as well as improvement [39] of hyperglycemia in rats with type 2 diabetes.

The morphological and histochemical properties of fibers in the skeletal muscle correspond well with those of spinal motoneurons that innervate muscle fibers [40., 41., 42., 43.]. A previous study [44] had shown decreased oxidative capacity of spinal motoneurons in rats with type 2 diabetes. In addition, this study [44] had examined the effects of exposure to mild hyperbaric oxygen on oxidative capacity of spinal motoneurons. The inhibition of growth-related decrease in oxidative capacity of spinal motoneurons by exposure to mild hyperbaric oxygen corresponds well with that observed in muscle fibers innervated by spinal motoneurons, thereby implying that the properties and responses of spinal motoneurons and their innervating muscle fibers are closely related under diabetic, as well as normal conditions [44].

Diabetes-induced cataracts

Cataracts are characterized by an accumulation of sorbitol, mediated by aldose reductase activity. The polyol pathway is the major contributor to diabetes-induced cataracts, i.e., the denaturation of lens protein, since an increased flux of glucose via this pathway leads to diabetic lesions in the lens, and large quantities of glucose are reduced to sorbitol, which is not metabolized any further [45]. The increased availability of oxygen by exposure to mild hyperbaric oxygen inhibited the growth-related increase in blood glucose levels in rats with type 2 diabetes, thereby delaying cataract formation induced by the accumulation of sorbitol in the lens [46].

Hypertension

Spontaneously hypertensive rats (SHRs) were developed by repeated inbreeding of normal Wistar–Kyoto rats, which exhibited high blood pressure levels [47]. SHRs exposed to mild hyperbaric oxygen showed lower systolic and diastolic blood pressure levels than those of age-matched SHRs not exposed to mild hyperbaric oxygen [5]. Furthermore, SHRs exposed to mild hyperbaric oxygen had lower oxidative stress and higher antioxidant levels than age-matched SHRs not exposed to mild hyperbaric oxygen [5]. Abnormalities of central neural mechanisms regulating the peripheral sympathetic outflow, i.e., an enhanced sympathetic activation and catecholamine metabolism following neurotransmitter release from nerve endings, have been associated with hypertension [48, 49]. An enhanced sympathetic activation in rats with hypertension is mediated by the overproduction of highly reactive oxygen species, which induces sympathoexcitation and thus hypertension [50, 51], whereas exposure to mild hyperbaric oxygen has been suggested to eliminate reactive oxygen species and maintain normal blood pressure levels [5]. An enhancement of oxidative metabolism in cells and tissues increases the carbon dioxide concentration in the surrounding region, which in turn, facilitates blood flow in blood vessels [52, 53].

Arthritis

Exposure to mild hyperbaric oxygen is effective in decreasing levels of reactive oxygen species overproduced in arthritis [19]. Oxidative stress and C-reactive protein levels are high in rats with arthritis [54], whereas the levels shifted to those in normal rats by exposure to mild hyperbaric oxygen [19]. Arthritic joints are characterized by hypoxia caused by an increased oxygen demand and decreased blood flow triggered by the increased intraarticular pressure [55., 56., 57.]. Therefore, exposure to mild hyperbaric oxygen is effective in reducing reactive oxygen species levels overproduced during arthritis [19].

Pigmentation and proliferation

The skin undergoes age-related degenerative changes, including tissue dehydration and transepidermal water loss [58]. Proliferation of epidermal basal cells decreases with age [59]. Exposure to mild hyperbaric oxygen has been reported to accelerate the proliferative activity of epidermal basal cells in aged mouse skin [60]. An adequate oxygen supply from exposure to mild hyperbaric oxygen may accelerate the turnover rate of aged skin by enhancing the proliferative activity of epidermal basal cells. Therefore, the dissolved oxygen, which is increased by exposure to mild hyperbaric oxygen, is considered to diffuse from the dermis to the epidermis through blood microcirculation, thus accelerating proliferation of epidermal basal cells and inhibiting epidermal aging [60].

Suppression of ultraviolet B irradiation-induced pigmentation is due, at least in part, to the reduction in prostaglandin synthesis via the inhibition of cyclooxygenase by indomethacin, and to the induction of annexin or lipocortin by corticosteroids [61]. Exposure to mild hyperbaric oxygen was found to accelerate the fading of ultraviolet B irradiation-induced melanin pigmentation of the skin [62]. Furthermore, senile spot sizes on faces became smaller after exposure to mild hyperbaric oxygen [62]. Keratinocyte proliferation and epidermal cell regeneration are considered to be activated by enhanced oxidative metabolism induced by exposure to mild hyperbaric oxygen, which may be effective for damage repair in the epidermis.

Adaptation of the neuromuscular system

Exposure to mild hyperbaric oxygen facilitates oxidative metabolism, particularly in pathways such as the mitochondrial tricarboxylic acid cycle, thus enhancing the oxidative capacity of skeletal muscle fibers and the spinal motoneurons innervating them [63, 64]. Growing rats exposed to mild hyperbaric oxygen exhibited greater voluntary running activities compared to those maintained under normobaric conditions (without exposure to mild hyperbaric oxygen); the oxidative capacity of muscle fibers and the innervating spinal motoneurons in rats increased after exposure to mild hyperbaric oxygen [64].

Reduction in skeletal muscle mass is one of the most striking features of the aging process [65]. Atrophy and reduced oxidative capacity of the skeletal muscle have been observed with age [66, 67]. Muscle atrophy in aged rats is associated with reduced activity levels of certain enzymes involved in oxidative metabolism [68]. An age-related decrease in oxidative capacity of the skeletal muscle in mice was reported to be reversed by exposure to mild hyperbaric oxygen [69] as much as by exercise in aged rats [70]. Exposure to mild hyperbaric oxygen has an advantage over exercise since it can increase the dissolved oxygen content owing to the enhanced atmospheric pressure and/or increased oxygen concentration, which does not occur in exercise. Therefore, it is concluded that exposure to mild hyperbaric oxygen reduces the age-related decrease in oxidative capacity of the skeletal muscle due to the improvement in oxidative metabolism [69].

Chronic inactivity, as in hind limb unloading and microgravity exposure, induces atrophy and degenerative changes in the skeletal muscle and its fibers [71., 72., 73., 74., 75.], as well as in spinal motoneurons that innervate the muscle fibers [76., 77., 78., 79., 80., 81., 82.]. Muscle atrophy and decreased oxidative capacity were shown to be unaffected by either pre- or post-conditioning with exposure to mild hyperbaric oxygen [83]. In contrast, the degenerative changes were almost restored to normal levels after reloading, when pre- and post-conditionings with exposure to mild hyperbaric oxygen were combined [83]. Only a combination of pre- and post-conditionings is considered to activate the signaling cascades required for the recovery from atrophy and decreased oxidative capacity of the skeletal muscle.

Parkinson’s disease

Parkinson’s disease is a progressive neurodegenerative disorder in the elderly that is characterized by typical motor symptoms such as resting tremors, rigidity, bradykinesia, and gait disturbances [84]. Parkinson’s disease results from the progressive decrease in dopaminergic neurons in the substantia nigra [85]. Exposure to mild hyperbaric oxygen was shown to inhibit the decrease in dopaminergic neurons in the substantia nigra of a neurotoxic experimental animal with Parkinson’s disease [86]. The number of times the feet of the mouse slid off the stick in a balance beam test was fewer in mice with Parkinson’s disease exposed to mild hyperbaric oxygen than in those not exposed to mild hyperbaric oxygen [86]. PGC-1α, a transcriptional co-activator, may be one of the factors that contribute to the improvement in oxidative metabolism of dopaminergic neurons in Parkinson’s disease [87], since oxidative metabolism, mitochondrial biogenesis, oxidative stress, and gene expression are regulated by PGC-1α [88, 89].

It is concluded that exposure to mild hyperbaric oxygen activates oxidative metabolism in the dopaminergic neurons in the substantia nigra and inhibits the reduction in dopaminergic neurons, thereby resulting in the inhibition of Parkinson’s disease [86].

Infertility

Hyperbaric oxygen therapy, an established medical treatment usually conducted under conditions of 2026–3039 hPa with 100% oxygen, has been investigated for improving female [90., 91., 92., 93.] and male [94, 95] infertility. However, several side effects, including barotrauma and excessive production of reactive oxygen species, associated with hyperbaric oxygen therapy, have been reported [7., 8., 9., 10., 11., 12., 14]. Low metabolism in the uterus and ovaries may be a factor responsible for infertility since the former reduces the ability of fertilized eggs to remain in the uterus. Exposure to mild hyperbaric oxygen has been suggested to enhance oxygen supply to cells and tissues, thus improving oxidative metabolism, without barotrauma and excessive production of reactive oxygen species. In a recent study [96], 37 women with intractable infertility, who had previously received over 5 embryo transfers with a low clinical pregnancy rate (4.9%) and without birth, were exposed to mild hyperbaric oxygen before receiving any further embryo transfer. As a result, 13 women achieved clinical pregnancy with a rate of 13.8%; 5 women gave birth after in vitro fertilization treatment. Two women achieved natural conception and gave birth. However, 1 woman had an extra-uterine pregnancy, and 5 women had miscarriages.

Perspectives on exposure to mild hyperbaric oxygen

Exposure to mild hyperbaric oxygen is effective for elderly people, those with physical disability, as well as injured athletes, since no special movement needs to be performed under mild hyperbaric oxygen conditions. In future, exposure to mild hyperbaric oxygen may be investigated for: (1) prevention and improvement of dementia, (2) improvement of functional imbalances of autonomic (sympathetic and parasympathetic) nerves, e.g., menopausal disorders and emotional instability, (3) maintenance and improvement of immunity, health, and physical fitness, and (4) early recovery from an injury. Further studies are required to solve these problems and define a useful protocol for exposure to mild hyperbaric oxygen.

Acknowledgments

Compliance with ethical standards

Ethical approval

This article does not contain any studies with animals or human participants performed by the author.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    P.M. Tibbles, J.S. Edelsberg

    Hyperbaric-oxygen therapy

    N Engl J Med, 334 (1996), pp. 1642-1648

    10.1056/NEJM199606203342506

    1:STN:280:DyaK283js1SktQ%3D%3D

    8628361

    View in ScopusGoogle Scholar

  2. 2.

    R.M. Leach, P.J. Rees, P. Wilmshurst

    Hyperbaric oxygen therapy

    BMJ, 317 (1998), pp. 1140-1143

    10.1136/bmj.317.7166.1140

    1:STN:280:DyaK1M%2FgtlSjsA%3D%3D

    9784458

    1114115

    CrossrefView in ScopusGoogle Scholar

  3. 3.

    A. Takemura, A. Ishihara

    Mild hyperbaric oxygen inhibits growth-related decrease in muscle oxidative capacity of rats with metabolic syndrome

    J Atheroscler Thromb, 24 (2017), pp. 26-38

    10.5551/jat.34686

    1:CAS:528:DC%2BC1cXitlCjsr3O

    27237220

    5225130

    CrossrefView in ScopusGoogle Scholar

  4. 4.

    K. Yasuda, N. Aoki, T. Adachi, G. Tsujimoto, N. Gu, T. Matsunaga, N. Kikuchi, K. Tsuda, A. Ishihara

    Hyperbaric exposure with high oxygen concentration inhibits growth-associated increase in the glucose level of diabetic Goto-Kakizaki rats

    Diabetes Obes Metab, 8 (2006), pp. 714-715

    10.1111/j.1463-1326.2005.00555.x

    1:STN:280:DC%2BD28rpsFKrsA%3D%3D

    17026499

    CrossrefView in ScopusGoogle Scholar

  5. 5.

    F. Nagatomo, H. Fujino, I. Takeda, A. Ishihara

    Effects of hyperbaric oxygenation on blood pressure levels of spontaneously hypertensive rats

    Clin Exp Hypertens, 32 (2010), pp. 193-197

    10.3109/10641960903254521

    1:CAS:528:DC%2BC3cXms1Olu7w%3D

    20504127

    CrossrefView in ScopusGoogle Scholar

  6. 6.

    F. Nagatomo, N. Gu, H. Fujino, I. Takeda, K. Tsuda, A. Ishihara

    Skeletal muscle characteristics of rats with obesity, diabetes, hypertension, and hyperlipidemia

    J Atheroscler Thromb, 16 (2009), pp. 576-585

    10.5551/jat.1065

    1:CAS:528:DC%2BD1MXhsV2jtrrJ

    19763017

    CrossrefView in ScopusGoogle Scholar

  7. 7.

    F.J. Giblin, V.A. Padgaonkar, V.R. Leverenz, L.R. Lin, M.F. Lou, N.J. Unakar, L. Dang, J.E. Dickerson Jr, V.N. Reddy

    Nuclear light scattering, disulfide formation and membrane damage in lenses of older guinea pigs treated with hyperbaric oxygen

    Exp Eye Res, 60 (1995), pp. 219-235

    10.1016/S0014-4835(05)80105-8

    1:CAS:528:DyaK2MXkvVCisL8%3D

    7789403

    View PDFView articleView in ScopusGoogle Scholar

  8. 8.

    B.M. Palmquist, B. Philipson, P.O. Barr

    Nuclear cataract and myopia during hyperbaric oxygen therapy

    Br J Ophthalmol, 68 (1984), pp. 113-117

    10.1136/bjo.68.2.113

    1:STN:280:DyaL2c7gsVOrsw%3D%3D

    6691953

    1040267

    CrossrefView in ScopusGoogle Scholar

  9. 9.

    L.B. Gesell, A. Trott

    De novo cataract development following a standard course of hyperbaric oxygen therapy

    Undersea Hyperb Med, 34 (2007), pp. 389-392

    1:STN:280:DC%2BD1c%2FpsVahsg%3D%3D

    18251434

    View in ScopusGoogle Scholar

  10. 10.

    R.J. Folz, A.M. Abushamaa, H.B. Suliman

    Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia

    J Clin Invest, 103 (1999), pp. 1055-1066

    10.1172/JCI3816

    1:CAS:528:DyaK1MXitlegsLs%3D

    10194479

    408251

    View in ScopusGoogle Scholar

  11. 11.

    S. Oter, A. Korkmaz, T. Topal, O. Ozcan, S. Sadir, M. Ozler, R. Ogur, H. Bilgic

    Correlation between hyperbaric oxygen exposure pressures and oxidative parameters in rat lung, brain, and erythrocytes

    Clin Biochem, 38 (2005), pp. 706-711

    10.1016/j.clinbiochem.2005.04.005

    1:CAS:528:DC%2BD2MXmsVais7Y%3D

    15904909

    View PDFView articleView in ScopusGoogle Scholar

  12. 12.

    S. Oter, T. Topal, S. Sadir, M. Ozler, B. Uysal, H. Ay, H. Yaren, A. Korhmaz, A. Akin

    Oxidative stress levels in rats following exposure to oxygen at 3 atm for 0–120 min

    Aviat Space Environ Med, 78 (2007), pp. 1108-1113

    10.3357/ASEM.2119.2007

    1:CAS:528:DC%2BD1cXhs1Cntg%3D%3D

    18064914

    CrossrefView in ScopusGoogle Scholar

  13. 13.

    V.A. Padgaonkar, V.R. Leverenz, K.E. Fowler, V.N. Reddy, F.J. Giblin

    The effects of hyperbaric oxygen on the crystallins of cultured rabbit lenses: a possible catalytic role for copper

    Exp Eye Res, 71 (2000), pp. 371-383

    10.1006/exer.2000.0887

    1:CAS:528:DC%2BD3cXmsFKlsro%3D

    10995558

    View PDFView articleView in ScopusGoogle Scholar

  14. 14.

    C.K. Narkowicz, J.H. Vial, P.W. McCartney

    Hyperbaric oxygen therapy increases free radical levels in the blood of humans

    Free Radic Res Commun, 19 (1993), pp. 71-80

    10.3109/10715769309056501

    1:CAS:528:DyaK2cXmt1Cr

    8225040

    CrossrefView in ScopusGoogle Scholar

  15. 15.

    C.M. Maier, P.H. Chan

    Role of superoxide dismutases in oxidative damage and neurodegenerative disorders

    Neuroscientist, 8 (2002), pp. 323-334

    10.1177/107385840200800408

    1:CAS:528:DC%2BD38XmsFWntLY%3D

    12194501

    CrossrefView in ScopusGoogle Scholar

  16. 16.

    K.K. Griendling, G.A. FitzGerald

    Oxidative stress and cardiovascular injury: part I: basic mechanisms and in vivo monitoring of ROS

    Circulation, 108 (2003), pp. 1912-1916

    10.1161/01.CIR.0000093660.86242.BB

    14568884

    View in ScopusGoogle Scholar

  17. 17.

    I. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini, A. Milzani

    Biomarkers of oxidative damage in human disease

    Clin Chem, 52 (2006), pp. 601-623

    10.1373/clinchem.2005.061408

    1:CAS:528:DC%2BD28Xjt1Gruro%3D

    16484333

    CrossrefView in ScopusGoogle Scholar

  18. 18.

    F. Nagatomo, H. Fujino, H. Kondo, A. Ishihara

    Oxygen concentration-dependent oxidative stress levels in rats

    Oxid Med Cell Longev (2012)

    10.1155/2012/381763

    22988483

    3440952

    Google Scholar

  19. 19.

    F. Nagatomo, N. Gu, H. Fujino, T. Okiura, F. Morimatsu, I. Takeda, A. Ishihara

    Effects of exposure to hyperbaric oxygen on oxidative stress in rats with type II collagen-induced arthritis

    Clin Exp Med, 10 (2010), pp. 7-13

    10.1007/s10238-009-0064-y

    1:CAS:528:DC%2BC3cXpsFamug%3D%3D

    19779965

    CrossrefView in ScopusGoogle Scholar

  20. 20.

    A. Ishihara, F. Nagatomo, H. Fujino, H. Kondo

    Exposure to mild hyperbaric oxygen increases blood flow and resting energy expenditure but not oxidative stress

    J Sci Res Rep, 3 (2014), pp. 1886-1896

    Google Scholar

  21. 21.

    F. Nagatomo, H. Fujino, H. Kondo, I. Takeda, K. Tsuda, A. Ishihara

    High-fat diet-induced reduction of PGC-1α mRNA levels and oxidative capacity in the soleus muscle of rats with metabolic syndrome

    Nutr Res, 32 (2012), pp. 144-151

    10.1016/j.nutres.2011.12.015

    1:CAS:528:DC%2BC38XjtV2rsLs%3D

    22348463

    View PDFView articleView in ScopusGoogle Scholar

  22. 22.

    F. Nagatomo, H. Fujino, H. Kondo, K. Kouzaki, N. Gu, I. Takeda, K. Tsuda, A. Ishihara

    The effects of running exercise on oxidative capacity and PGC-1α mRNA levels in the soleus muscle of rats with metabolic syndrome

    J Physiol Sci, 62 (2012), pp. 105-114

    10.1007/s12576-011-0188-1

    1:CAS:528:DC%2BC38XjtVCqsLw%3D

    22234788

    View PDFView articleCrossrefView in ScopusGoogle Scholar

  23. 23.

    S. Koletsky

    Obese spontaneously hypertensive rats–a model for study of atherosclerosis

    Exp Mol Pathol, 19 (1973), pp. 53-60

    10.1016/0014-4800(73)90040-3

    1:STN:280:DyaE3s3islCjsQ%3D%3D

    4721724

    View PDFView articleView in ScopusGoogle Scholar

  24. 24.

    S. Koletsky

    Pathologic findings and laboratory data in a new strain of obese hypertensive rats

    Am J Pathol, 80 (1975), pp. 129-142

    1:STN:280:DyaE2M3it1Ohug%3D%3D

    1171627

    1912834

    View in ScopusGoogle Scholar

  25. 25.

    F. Nagatomo, H. Fujino, H. Kondo, N. Gu, I. Takeda, N. Ishioka, K. Tsuda, A. Ishihara

    PGC-1α mRNA level and oxidative capacity of the plantaris muscle in rats with metabolic syndrome, hypertension, and type 2 diabetes

    Acta Histochem Cytochem, 44 (2011), pp. 73-80

    10.1267/ahc.10041

    1:CAS:528:DC%2BC3MXmtVOjtb8%3D

    21614168

    3096084

    CrossrefView in ScopusGoogle Scholar

  26. 26.

    S. Miura, Y. Kai, M. Ono, O. Ezaki

    Overexpression of peroxisome proliferator-activated receptor γ coactivator-1α down-regulates GLUT4 mRNA in skeletal muscles

    J Biol Chem, 278 (2003), pp. 31385-31390

    10.1074/jbc.M304312200

    1:CAS:528:DC%2BD3sXmtFCjsrg%3D

    12777397

    View PDFView articleView in ScopusGoogle Scholar

  27. 27.

    O.H. Mortensen, L. Frandsen, P. Schjerling, E. Nishimura, N. Grunnet

    PGC-1α and PGC-1β have both similar and distinct effects on myofiber switching towards an oxidative phenotype

    Am J Physiol Endocrinol Metab, 291 (2006), pp. E807-E816

    10.1152/ajpendo.00591.2005

    1:CAS:528:DC%2BD28XhtFarsLzI

    16720625

    CrossrefView in ScopusGoogle Scholar

  28. 28.

    A. Ishihara, F. Nagatomo, H. Fujino, H. Kondo, K. Tsuda

    Lifestyle-related disease and skeletal muscle

    J Phys Fit Sports Med, 1 (2012), pp. 17-27

    10.7600/jpfsm.1.17

    CrossrefGoogle Scholar

  29. 29.

    Y. Goto, M. Kakizaki, N. Masaki

    Spontaneous diabetes produced by selective breeding of normal Wistar rats

    Proc Jpn Acad, 51 (1975), pp. 80-85

    10.2183/pjab1945.51.80

    CrossrefGoogle Scholar

  30. 30.

    Y. Goto, M. Kakizaki, N. Masaki

    Production of spontaneous diabetic rats by repetition of selective breeding

    Tohoku J Exp Med, 119 (1976), pp. 85-90

    10.1620/tjem.119.85

    1:CAS:528:DyaE28Xks1Smt7Y%3D

    951706

    CrossrefView in ScopusGoogle Scholar

  31. 31.

    K. Kawano, T. Hirashima, S. Mori, Y. Saitoh, M. Kurosumi, T. Natori

    Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain

    Diabetes, 41 (1992), pp. 1422-1428

    10.2337/diab.41.11.1422

    1:STN:280:DyaK3s%2Fht1GitA%3D%3D

    1397718

    CrossrefView in ScopusGoogle Scholar

  32. 32.

    K. Yasuda, A. Ishihara, T. Adachi, N. Shihara, Y. Seino, K. Tsuda

    Growth-related changes in skeletal muscle fiber type and insulin resistance in diabetic Otsuka Long-Evans Tokushima Fatty rats

    Acta Histochem Cytochem, 34 (2001), pp. 371-382

    10.1267/ahc.34.371

    View in ScopusGoogle Scholar

  33. 33.

    K. Yasuda, W. Nishikawa, N. Iwanaka, E. Nakamura, Y. Seino, K. Tsuda, A. Ishihara

    Abnormality in fibre type distribution of soleus and plantaris muscles in non-obese diabetic Goto-Kakizaki rats

    Clin Exp Pharmacol Physiol, 29 (2002), pp. 1001-1008

    10.1046/j.1440-1681.2002.03757.x

    1:CAS:528:DC%2BD38XnslSks7s%3D

    12366392

    View in ScopusGoogle Scholar

  34. 34.

    K. Yasuda, T. Adachi, N. Kikuchi, G. Tsujimoto, N. Aoki, K. Tsuda, A. Ishihara

    Effects of running exercise on fibre-type distribution of soleus and plantaris muscles in diabetic Otsuka Long-Evans Tokushima fatty rats

    Diabetes Obes Metab, 8 (2006), pp. 311-321

    10.1111/j.1463-1326.2005.00507.x

    1:CAS:528:DC%2BD28XkvVaju7w%3D

    16634991

    View at publisherCrossrefView in ScopusGoogle Scholar

  35. 35.

    T. Adachi, N. Kikuchi, K. Yasuda, R. Anahara, N. Gu, T. Matsunaga, T. Yamamura, C. Mori, G. Tsujimoto, K. Tsuda, A. Ishihara

    Fibre type distribution and gene expression levels of both succinate dehydrogenase and peroxisome proliferator-activated receptor-γ coactivator-1α of fibres in the soleus muscle of Zucker diabetic fatty rats

    Exp Physiol, 92 (2007), pp. 449-455

    10.1113/expphysiol.2006.035451

    1:CAS:528:DC%2BD2sXkvFegsLo%3D

    17158179

    View at publisherCrossrefView in ScopusGoogle Scholar

  36. 36.

    K. Yasuda, T. Adachi, N. Gu, A. Matsumoto, T. Matsunaga, G. Tsujimoto, K. Tsuda, A. Ishihara

    Effects of hyperbaric exposure with high oxygen concentration on glucose and insulin levels and skeletal muscle-fiber properties in diabetic rats

    Muscle Nerve, 35 (2007), pp. 337-343

    10.1002/mus.20692

    1:CAS:528:DC%2BD2sXjvFSmtbc%3D

    17094100

    CrossrefView in ScopusGoogle Scholar

  37. 37.

    A. Matsumoto, F. Nagatomo, K. Yasuda, K. Tsuda, A. Ishihara

    Hyperbaric exposure with high oxygen concentration improves altered fiber types in the plantaris muscle of diabetic Goto-Kakizaki rats

    J Physiol Sci, 57 (2007), pp. 133-136

    10.2170/physiolsci.SC000707

    1:STN:280:DC%2BD2s3ks1anug%3D%3D

    17349108

    View in ScopusGoogle Scholar

  38. 38.

    F. Nagatomo, A. Takemura, R.R. Roy, H. Fujino, H. Kondo, A. Ishihara

    Mild hyperbaric oxygen inhibits the growth-related decline in skeletal muscle oxidative capacity and prevents hyperglycemia in rats with type 2 diabetes

    J Diabetes, 10 (2018), pp. 753-763

    10.1111/1753-0407.12666

    1:CAS:528:DC%2BC1cXhs1Sntr3I

    29633563

    CrossrefView in ScopusGoogle Scholar

  39. 39.

    N. Gu, F. Nagatomo, H. Fujino, I. Takeda, K. Tsuda, A. Ishihara

    Hyperbaric oxygen exposure improves blood glucose level and muscle oxidative capacity in rats with type 2 diabetes

    Diabetes Technol Ther, 12 (2010), pp. 125-133

    10.1089/dia.2009.0104

    1:CAS:528:DC%2BC3cXhtFOitL8%3D

    20105042

    CrossrefView in ScopusGoogle Scholar

  40. 40.

    A. Ishihara, R.R. Roy, V.R. Edgerton

    Succinate dehydrogenase activity and soma size of motoneurons innervating different portions of the rat tibialis anterior

    Neuroscience, 68 (1995), pp. 813-822

    10.1016/0306-4522(95)00165-F

    1:CAS:528:DyaK2MXnslWks7g%3D

    8577376

    View PDFView articleView in ScopusGoogle Scholar

  41. 41.

    A. Ishihara, A. Hori, R.R. Roy, Y. Oishi, R.J. Talmadge, Y. Ohira, S. Kobayashi, V.R. Edgerton

    Perineal muscles and their innervation: metabolic and functional significance of the motor unit

    Acta Anat, 159 (1997), pp. 156-166

    10.1159/000147979

    1:STN:280:DyaK1c3js1akug%3D%3D

    9575366

    CrossrefView in ScopusGoogle Scholar

  42. 42.

    A. Ishihara, K. Itoh, M. Itoh, C. Hirofuji

    Effect of hypobaric hypoxia on rat soleus muscle fibers and their innervating motoneurons: a review

    Jpn J Physiol, 50 (2000), pp. 561-568

    10.2170/jjphysiol.50.561

    1:STN:280:DC%2BD3MzptlGmtA%3D%3D

    11173551

    CrossrefView in ScopusGoogle Scholar

  43. 43.

    T. Nakatani, T. Nakashima, T. Kita, A. Ishihara

    Cell size and oxidative enzyme activity of type-identified fibers in rat hindlimb muscles: a review

    Acta Histochem Cytochem, 36 (2003), pp. 105-114

    10.1267/ahc.36.105

    1:CAS:528:DC%2BD3sXjvVSns7Y%3D

    View in ScopusGoogle Scholar

  44. 44.

    A. Takemura, A. Ishihara

    Mild hyperbaric oxygen improves decreased oxidative capacity of spinal motoneurons innervating the soleus muscle of rats with type 2 diabetes

    Neurochem Res, 41 (2016), pp. 2336-2344

    10.1007/s11064-016-1947-4

    1:CAS:528:DC%2BC28Xos1WrsLY%3D

    27220333

    View at publisherCrossrefView in ScopusGoogle Scholar

  45. 45.

    S.S.M. Chung, E.C.M. Ho, K.S.L. Lam, S.K. Chung

    Contribution of polyol pathway to diabetes-induced oxidative stress

    J Am Soc Nephrol, 14 (Suppl 3) (2003), pp. 233-236

    10.1097/01.ASN.0000077408.15865.06

    1:CAS:528:DC%2BD3sXmslCqsL8%3D

    View at publisherCrossrefGoogle Scholar

  46. 46.

    F. Nagatomo, R.R. Roy, H. Takahashi, V.R. Edgerton, A. Ishihara

    Effect of exposure to hyperbaric oxygen on diabetes-induced cataracts in mice

    J Diabetes, 3 (2011), pp. 301-308

    10.1111/j.1753-0407.2011.00150.x

    1:CAS:528:DC%2BC38Xms1yg

    21801331

    View at publisherCrossrefView in ScopusGoogle Scholar

  47. 47.

    K. Okamoto, K. Aoki

    Development of a strain of spontaneously hypertensive rats

    Jpn Circ J, 27 (1963), pp. 282-293

    10.1253/jcj.27.282

    1:STN:280:DyaF387jtFCmsw%3D%3D

    13939773

    View at publisherCrossrefView in ScopusGoogle Scholar

  48. 48.

    K.P. Patel, R.L. Kline, P.F. Mercer

    Noradrenergic mechanisms in the brain and peripheral organs of normotensive and spontaneously hypertensive rats at various ages

    Hypertension, 3 (1981), pp. 682-690

    10.1161/01.HYP.3.6.682

    1:CAS:528:DyaL38XkvF2gsA%3D%3D

    6117514

    View in ScopusGoogle Scholar

  49. 49.

    G. Grassi

    Role of the sympathetic nervous system in human hypertension

    J Hypertens, 16 (1998), pp. 1979-1987

    10.1097/00004872-199816121-00019

    1:STN:280:DyaK1M7gt1Sjsw%3D%3D

    9886886

    View in ScopusGoogle Scholar

  50. 50.

    T. Kishi, Y. Hirooka, Y. Kimura, K. Ito, H. Shimokawa, A. Takeshita

    Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats

    Circulation, 109 (2004), pp. 2357-2362

    10.1161/01.CIR.0000128695.49900.12

    1:CAS:528:DC%2BD2cXjslOru7k%3D

    15117836

    View in ScopusGoogle Scholar

  51. 51.

    T.E. Lindley, M.F. Doobay, R.V. Sharma, R.I. Davisson

    Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure

    Circ Res, 94 (2004), pp. 402-409

    10.1161/01.RES.0000112964.40701.93

    1:CAS:528:DC%2BD2cXhtFWksr4%3D

    14684626

    View in ScopusGoogle Scholar

  52. 52.

    T. Matsumoto, M. Tanaka, T. Ikeji, N. Maeshige, Y. Sakai, T. Akisue, H. Kondo, A. Ishihara, H. Fujino

    Application of transcutaneous carbon dioxide improves capillary regression of skeletal muscle in hyperglycemia

    J Physiol Sci, 69 (2019), pp. 317-326

    10.1007/s12576-018-0648-y

    1:CAS:528:DC%2BC1cXisVaks7jJ

    30478742

    View PDFView articleCrossrefView in ScopusGoogle Scholar

  53. 53.

    Matsumoto T, Tanaka M, Nakanishi R, Takuwa M, Hirabayashi T, Ono K, Ikeji T, Maeshige N, Sakai Y, Akisue T, Kondo K, Ishihara A, Fujino H (2019) Transcutaneous carbon dioxide attenuates impaired oxidative capacity in skeletal muscle in hyperglycemia. Gen Physiol Biophys (accepted)

    Google Scholar

  54. 54.

    T. Okiura, F. Nagatomo, N. Gu, Y. Taguchi, F. Morimatsu, A. Ishihara

    Bone density of the femur and fiber cross-sectional area and oxidative enzyme activity of the tibialis anterior muscle in type II collagen-induced arthritic mice

    J Physiol Sci, 58 (2008), pp. 221-227

    10.2170/physiolsci.RP003708

    18534044

    View in ScopusGoogle Scholar

  55. 55.

    T. Woodruff, D.R. Blake, J. Freeman, F.J. Andrews, P. Salt, J. Lunec

    Is chronic synovitis an example of reperfusion injury?

    Ann Rheum Dis, 45 (1986), pp. 608-611

    10.1136/ard.45.7.608

    1:CAS:528:DyaL28XkvFGgt7c%3D

    3755583

    1001946

    View PDFView articleCrossrefView in ScopusGoogle Scholar

  56. 56.

    C.E. Cross, B. Halliwell, E.T. Borish, W.A. Pryor, B.N. Ames, R.L. Saul, J.M. McCord, D. Harman

    Oxygen radicals and human disease

    Ann Intern Med, 107 (1987), pp. 526-545

    10.7326/0003-4819-107-4-526

    1:STN:280:DyaL2szisVGlsQ%3D%3D

    3307585

    CrossrefView in ScopusGoogle Scholar

  57. 57.

    D.R. Blake, P. Merry, J. Unsworth, B.L. Kidd, J.M. Outhwaite, R. Ballard, C.J. Morris, L. Gray, J. Lunec

    Hypoxic-reperfusion injury in the inflamed human joint

    Lancet, 11 (1989), pp. 289-293

    10.1016/S0140-6736(89)91305-6

    View PDFView articleView in ScopusGoogle Scholar

  58. 58.

    K.P. Wilhelm, A.B. Cua, H.I. Maibach

    Skin aging: effect on transepidermal water loss, stratum corneum hydration, skin surface pH, and casual sebum content

    Arch Dermatol, 127 (1991), pp. 1806-1809

    10.1001/archderm.1991.04520010052006

    1:STN:280:DyaK3szgsV2ksA%3D%3D

    1845280

    CrossrefView in ScopusGoogle Scholar

  59. 59.

    G.L. Grove, A.M. Kligman

    Age-associated changes in human epidermal cell renewal

    J Gerontol, 38 (1983), pp. 137-142

    10.1093/geronj/38.2.137

    1:STN:280:DyaL3s7js12isQ%3D%3D

    6827031

    CrossrefView in ScopusGoogle Scholar

  60. 60.

    T. Nishizaka, T. Nomura, K. Higuchi, A. Takemura, A. Ishihara

    Mild hyperbaric oxygen activates the proliferation of epidermal basal cells in aged mice

    J Dermatol, 45 (2018), pp. 1141-1144

    10.1111/1346-8138.14484

    1:CAS:528:DC%2BC1cXhs1GmurvN

    29855082

    CrossrefView in ScopusGoogle Scholar

  61. 61.

    R.J. Flower

    Background and discovery of lipocortins

    Agents Actions, 17 (1986), pp. 255-262

    10.1007/BF01982616

    1:STN:280:DyaL287otlemtw%3D%3D

    2938452

    View in ScopusGoogle Scholar

  62. 62.

    T. Nishizaka, T. Nomura, T. Sano, K. Higuchi, F. Nagatomo, A. Ishihara

    Hyperbaric oxygen improves UVB irradiation-induced melanin pigmentation and diminishes senile spot size

    Skin Res Tech, 17 (2011), pp. 332-338

    10.1111/j.1600-0846.2011.00502.x

    CrossrefView in ScopusGoogle Scholar

  63. 63.

    A. Ishihara, F. Kawano, T. Okiura, F. Morimatsu, Y. Ohira

    Hyperbaric exposure with high oxygen concentration enhances oxidative capacity of neuromuscular units

    Neurosci Res, 52 (2005), pp. 146-152

    10.1016/j.neures.2005.03.001

    1:CAS:528:DC%2BD2MXktVGmtr4%3D

    15893575

    View PDFView articleView in ScopusGoogle Scholar

  64. 64.

    A. Matsumoto, T. Okiura, F. Morimatsu, Y. Ohira, A. Ishihara

    Effects of hyperbaric exposure with high oxygen concentration on the physical activity of developing rats

    Dev Neurosci, 29 (2007), pp. 452-459

    10.1159/000097319

    1:CAS:528:DC%2BD2sXhtVyntbjE

    17119320

    CrossrefView in ScopusGoogle Scholar

  65. 65.

    S. Schiaffino, K.A. Dyar, S. Ciciliot, B. Blaauw, M. Sandri

    Mechanisms regulating skeletal muscle growth and atrophy

    FEBS J, 280 (2013), pp. 4294-4314

    10.1111/febs.12253

    1:CAS:528:DC%2BC3sXht1ymu7nK

    23517348

    CrossrefView in ScopusGoogle Scholar

  66. 66.

    A. Ishihara, H. Naitoh, S. Katsuta

    Effects of ageing on the total number of muscle fibers and motoneurons of the tibialis anterior muscles in the rat

    Brain Res, 435 (1987), pp. 355-358

    10.1016/0006-8993(87)91624-6

    1:STN:280:DyaL1c7gvVyqsg%3D%3D

    3427464

    View PDFView articleView in ScopusGoogle Scholar

  67. 67.

    A. Ishihara, H. Araki

    Effects of age on the number and histochemical properties of muscle fibers and motoneurons in the rat extensor digitorum longus muscle

    Mech Ageing Dev, 45 (1988), pp. 213-221

    10.1016/0047-6374(88)90003-6

    1:STN:280:DyaL1M7otVamsA%3D%3D

    3236905

    View PDFView articleView in ScopusGoogle Scholar

  68. 68.

    C. Hirofuji, A. Ishihara, R.R. Roy, K. Itoh, M. Itoh, V.R. Edgerton, S. Katsuta

    SDH activity and cell size of tibialis anterior motoneurons and muscle fibers in SAMP6

    Neuroreport, 11 (2000), pp. 823-828

    10.1097/00001756-200003200-00033

    1:STN:280:DC%2BD3c3hvVCmsQ%3D%3D

    10757527

    View in ScopusGoogle Scholar

  69. 69.

    T. Nishizaka, F. Nagatomo, H. Fujino, T. Nomura, T. Sano, K. Higuchi, I. Takeda, A. Ishihara

    Hyperbaric oxygen exposure reduces age-related decrease in oxidative capacity of the tibialis anterior muscle in mice

    Enzyme Res (2010)

    10.4061/2010/824763

    21048870

    2962912

    Google Scholar

  70. 70.

    A. Ishihara, S. Taguchi

    Effect of exercise on age-related muscle atrophy

    Neurobiol Aging, 14 (1993), pp. 331-335

    10.1016/0197-4580(93)90118-U

    1:STN:280:DyaK3szns1Wmuw%3D%3D

    8367014

    View PDFView articleView in ScopusGoogle Scholar

  71. 71.

    A. Ishihara, Y. Oishi, R.R. Roy, V.R. Edgerton

    Influence of two weeks of non-weight bearing on rat soleus motoneurons and muscle fibers

    Aviat Space Environ Med, 68 (1997), pp. 421-425

    1:STN:280:DyaK2s3ovVyhsw%3D%3D

    9143753

    View in ScopusGoogle Scholar

  72. 72.

    A. Ishihara, F. Kawano, N. Ishioka, H. Oishi, A. Higashibata, T. Shimazu, Y. Ohira

    Effects of running exercise during recovery from hindlimb unloading on soleus muscle fibers and their spinal motoneurons in rats

    Neurosci Res, 48 (2004), pp. 119-127

    10.1016/j.neures.2003.10.013

    1:CAS:528:DC%2BD2cXltV2ltA%3D%3D

    14741386

    View PDFView articleView in ScopusGoogle Scholar

  73. 73.

    A. Ishihara, H. Fujino, F. Nagatomo, I. Takeda, Y. Ohira

    Gene expression levels of heat shock proteins in the soleus and plantaris muscles of rats after hindlimb suspension or spaceflight

    J Physiol Sci, 58 (2008), pp. 413-417

    10.2170/physiolsci.RP000808

    1:CAS:528:DC%2BD1MXhtVKhs70%3D

    18845059

    View in ScopusGoogle Scholar

  74. 74.

    F. Nagatomo, H. Fujino, H. Kondo, H. Suzuki, M. Kouzaki, I. Takeda, A. Ishihara

    PGC-1α and FOXO1 mRNA levels and fiber characteristics of the soleus and plantaris muscles in rats after hindlimb unloading

    Histol Histopathol, 26 (2011), pp. 1545-1553

    1:CAS:528:DC%2BC38XjsF2rsLo%3D

    21972093

    View in ScopusGoogle Scholar

  75. 75.

    A. Ishihara, F. Nagatomo, M. Terada, H. Fujino, H. Kondo, N. Ishioka

    Effects of microgravity on the mouse triceps brachii muscle

    Muscle Nerve, 52 (2015), pp. 63-68

    10.1002/mus.24491

    25307981

    CrossrefView in ScopusGoogle Scholar

  76. 76.

    A. Ishihara, Y. Ohira, R.R. Roy, S. Nagaoka, C. Sekiguchi, W.E. Hinds, V.R. Edgerton

    Influence of spaceflight on succinate dehydrogenase activity and soma size of rat ventral horn neurons

    Acta Anat, 157 (1996), pp. 303-308

    10.1159/000147892

    1:CAS:528:DyaK2sXlt1ajsrc%3D

    9259879

    CrossrefView in ScopusGoogle Scholar

  77. 77.

    A. Ishihara, Y. Ohira, R.R. Roy, S. Nagaoka, C. Sekiguchi, W.E. Hinds, V.R. Edgerton

    Effects of 14 days of spaceflight and nine days of recovery on cell body size and succinate dehydrogenase activity of rat dorsal root ganglion neurons

    Neuroscience, 81 (1997), pp. 275-279

    10.1016/S0306-4522(97)00097-3

    1:CAS:528:DyaK2sXlvVWnsLo%3D

    9300420

    View PDFView articleView in ScopusGoogle Scholar

  78. 78.

    A. Ishihara, Y. Ohira, R.R. Roy, S. Nagaoka, C. Sekiguchi, W.E. Hinds, V.R. Edgerton

    Comparison of the response of motoneurons innervating perineal and hind limb muscles to spaceflight and recovery

    Muscle Nerve, 23 (2000), pp. 753-762

    10.1002/(SICI)1097-4598(200005)23:5%3C753::AID-MUS13%3E3.0.CO;2-J

    1:STN:280:DC%2BD3c3lvF2ltg%3D%3D

    10797399

    View in ScopusGoogle Scholar

  79. 79.

    A. Ishihara, Y. Ohira, R.R. Roy, S. Nagaoka, C. Sekiguchi, W.E. Hinds, V.R. Edgerton

    Succinate dehydrogenase activity in rat dorsolateral ventral horn motoneurons at L6 after spaceflight and recovery

    J Gravit Physiol, 9 (2002), pp. 39-48

    14638458

    Google Scholar

  80. 80.

    A. Ishihara, J. Yamashiro, A. Matsumoto, A. Higashibata, N. Ishioka, T. Shimazu, Y. Ohira

    Comparison of cell body size and oxidative enzyme activity in motoneurons between the cervical and lumbar segments in the rat spinal cord after spaceflight and recovery

    Neurochem Res, 31 (2006), pp. 411-415

    10.1007/s11064-005-9027-1

    1:CAS:528:DC%2BD28XltV2isb4%3D

    16733817

    CrossrefView in ScopusGoogle Scholar

  81. 81.

    F. Nagatomo, A. Ishihara, Y. Ohira

    Effects of hindlimb unloading at early postnatal growth on cell body size in spinal motoneurons innervating soleus muscle of rats

    Int J Dev Neurosci, 27 (2009), pp. 21-26

    10.1016/j.ijdevneu.2008.10.007

    19041389

    View PDFView articleCrossrefView in ScopusGoogle Scholar

  82. 82.

    A. Ishihara, F. Nagatomo, H. Fujino, H. Kondo, Y. Ohira

    Decreased succinate dehydrogenase activity of gamma and alpha motoneurons in mouse spinal cords following 13 weeks of exposure to microgravity

    Neurochem Res, 38 (2013), pp. 2160-2167

    10.1007/s11064-013-1124-y

    1:CAS:528:DC%2BC3sXht1Ohs73M

    23943522

    CrossrefView in ScopusGoogle Scholar

  83. 83.

    A. Takemura, R.R. Roy, I. Yoshihara, A. Ishihara

    Unloading-induced atrophy and decreased oxidative capacity of the soleus muscle in rats are reversed by pre- and postconditioning with mild hyperbaric oxygen

    Physiol Rep, 5 (2017), p. e13353

    10.14814/phy2.13353

    1:CAS:528:DC%2BC2sXht1ensLjP

    28743823

    5532487

    CrossrefView in ScopusGoogle Scholar

  84. 84.

    C.H. Adler

    Nonmotor complications in Parkinson’s disease

    Mov Disord, 20 (Suppl 11) (2005), pp. S23-S29

    10.1002/mds.20460

    15822106

    CrossrefView in ScopusGoogle Scholar

  85. 85.

    W. Dauer, S. Przedborski

    Parkinson’s disease: mechanisms and models

    Neuron, 39 (2003), pp. 889-909

    10.1016/S0896-6273(03)00568-3

    1:CAS:528:DC%2BD3sXnsFait7o%3D

    12971891

    View PDFView articleView in ScopusGoogle Scholar

  86. 86.

    Y. Kusuda, A. Takemura, M. Nakano, A. Ishihara

    Mild hyperbaric oxygen inhibits the decrease of dopaminergic neurons in the substantia nigra of mice with MPTP-induced Parkinson’s disease

    Neurosci Res, 132 (2018), pp. 58-62

    10.1016/j.neures.2017.11.008

    1:CAS:528:DC%2BC2sXhvFejsbvN

    29196223

    View PDFView articleView in ScopusGoogle Scholar

  87. 87.

    G. Mudò, J. Mäkelä, V. Di Liberto, T.V. Tselykh, M. Olivieri, P. Piepponen, O. Eriksson, A. Mälkiä, A. Bonomo, M. Kairisalo, J.A. Aguirre, L. Korhonen, N. Belluardo, D. Lindholm

    Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease

    Cell Mol Life Sci, 69 (2012), pp. 1153-1165

    10.1007/s00018-011-0850-z

    1:CAS:528:DC%2BC38Xjslehs74%3D

    21984601

    CrossrefView in ScopusGoogle Scholar

  88. 88.

    Z. Wu, P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, A. Troy, S. Cinti, B. Lowell, R.C. Scarpulla, B.M. Spiegelman

    Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1

    Cell, 98 (1999), pp. 115-124

    10.1016/S0092-8674(00)80611-X

    1:CAS:528:DyaK1MXks1Kktrs%3D

    10412986

    View PDFView articleView in ScopusGoogle Scholar

  89. 89.

    H. Liang, W.F. Ward

    PGC-1α: a key regulator of energy metabolism

    Adv Physiol Educ, 30 (2006), pp. 145-151

    10.1152/advan.00052.2006

    17108241

    CrossrefView in ScopusGoogle Scholar

  90. 90.

    S.A. Zadoev, V.V. Evdokimov, V.B. Rumiantsev, E.O. Osmolovskiĭ

    Hyperbaric oxygenation in the treatment of patients with chronic congestive prostatitis and lower fertility

    Urologiia, 1 (2001), pp. 27-30

    View in ScopusGoogle Scholar

  91. 91.

    J. Leverment, R. Turner, M. Bowman, C.J. Cooke

    Report of the use of hyperbaric oxygen therapy (HBO2) in an unusual case of secondary infertility

    Undersea Hyperb Med, 31 (2004), pp. 245-250

    1:STN:280:DC%2BD2crhsVygsw%3D%3D

    15485087

    View in ScopusGoogle Scholar

  92. 92.

    B.J. Van Voorhis, J.E. Greensmith, A. Dokras, A.E. Sparks, S.T. Simmons, C.H. Syrop

    Hyperbaric oxygen and ovarian follicular stimulation for in vitro fertilization: a pilot study

    Fertil Steril, 83 (2005), pp. 226-228

    10.1016/j.fertnstert.2004.05.101

    15652917

    View PDFView articleView in ScopusGoogle Scholar

  93. 93.

    A. Mitrović, B. Nikolić, S. Dragojević

    Hyperbaric oxygenation as a possible therapy of choice for infertility treatment

    Bosn J Basic Med Sci, 6 (2006), pp. 21-24

    10.17305/bjbms.2006.3168

    16879108

    CrossrefView in ScopusGoogle Scholar

  94. 94.

    A. Mitrović, P. Brkić, T. Jovanović

    The effects of hyperbaric oxygen treatment on vigility of spermatozoids: preliminary report

    Acta Physiol Hung, 98 (2011), pp. 85-90

    10.1556/APhysiol.98.2011.1.10

    21388934

    View in ScopusGoogle Scholar

  95. 95.

    A.Y. Metelev, A.B. Bogdanov, E.V. Ivkinl, A.A. Mitrokhin, M.M. Vodneva, E.L. Veliev

    Hyperbaric oxygen therapy in the treatment of male infertility associated with increased sperm DNA fragmentation and reactive oxygen species in semen

    Urologiia, 5 (2015), pp. 74-76

    View in ScopusGoogle Scholar

  96. 96.

    Yoshikawa F, Netsu Y, Shimizu T, Ishihara A (2019) Mild hyperbaric oxygen improves the outcome of infertility treatment. J Reprod Med (accepted)

    Google Scholar

Cited by (46)

Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics

2022, Redox Biology

Show abstract

Oxygen Atom-Concentrating Short Fibrous Sponge Regulates Cellular Respiration for Wound Healing

2023, Advanced Fiber Materials

Telomere Length: A Cardiovascular Biomarker and a Novel Therapeutic Target

2022, International Journal of Molecular Sciences

Chronic wounds: Treatment consensus

2022, Wound Repair and Regeneration

Role of telomeres shortening in atherogenesis: An overview

2021, Cells

Hyperbaric Oxygen Therapy: Descriptive Review of the Technology and Current Application in Chronic Wounds

2020, Plastic and Reconstructive Surgery Global Open

Written by Akihiko Ishihara - The Journal of Physiological Sciences Volume 69, Issue 4, July 2019, Pages 573-580